000 01261 a2200337 4500
005 20250514210919.0
264 0 _c20050308
008 200503s 0 0 eng d
022 _a1444-0903
024 7 _a10.1111/j.1445-5994.2004.00674.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSahhar, J
245 0 0 _aFibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
_h[electronic resource]
260 _bInternal medicine journal
_cNov 2004
300 _a626-38 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBronchoalveolar Lavage Fluid
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLung
_xdiagnostic imaging
650 0 4 _aMass Screening
650 0 4 _aPulmonary Fibrosis
_xdiagnosis
650 0 4 _aRespiratory Function Tests
650 0 4 _aScleroderma, Systemic
_xcomplications
650 0 4 _aTomography, X-Ray Computed
700 1 _aLittlejohn, G
700 1 _aConron, M
773 0 _tInternal medicine journal
_gvol. 34
_gno. 11
_gp. 626-38
856 4 0 _uhttps://doi.org/10.1111/j.1445-5994.2004.00674.x
_zAvailable from publisher's website
999 _c15233062
_d15233062